DR. STEPHEN A. HILL

Corporate Board Profile

Tech Score: 0/100

GYRE THERAPEUTICS, INC.

Filing Date	Source Excerpt
2013-04-17	Dr. Hill’s service as a director enables the Board to perform its responsibilities with the direct benefit of management’s perspectives. In addition, he brings to the Board extensive experience across a range of senior management positions with both pharmaceutical and biotechnology companies. Prior to Solvay and ArQule, Dr. Hill held several leadership positions with F. Hoffmann-La Roche Ltd., including Global Head of Clinical Development, and served for seven years with the National Health Service in the United Kingdom in General and Orthopedic Surgery.
2014-04-18	Dr. Hill has been a member of the board and our President and Chief Executive Officer since December 2012... Dr. Hill's service as a director enables the Board to perform its responsibilities with the direct benefit of management's perspectives. In addition, he brings to the Board extensive experience across a range of senior management positions with both pharmaceutical and biotechnology companies.

Filing Date

Source Excerpt

2013-04-17

Dr. Hill’s service as a director enables the Board to perform its responsibilities with the direct benefit of management’s perspectives. In addition, he brings to the Board extensive experience across a range of senior management positions with both pharmaceutical and biotechnology companies. Prior to Solvay and ArQule, Dr. Hill held several leadership positions with F. Hoffmann-La Roche Ltd., including Global Head of Clinical Development, and served for seven years with the National Health Service in the United Kingdom in General and Orthopedic Surgery.

2014-04-18

Dr. Hill has been a member of the board and our President and Chief Executive Officer since December 2012... Dr. Hill's service as a director enables the Board to perform its responsibilities with the direct benefit of management's perspectives. In addition, he brings to the Board extensive experience across a range of senior management positions with both pharmaceutical and biotechnology companies.

Data sourced from SEC filings. Last updated: 2026-02-03